Revenue segments as reported by the company.

Smokeable Products

Oral Tobacco Products

Wine

All Other

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Marketing, administration and research costs

Asset impairment and exit costs

Amortization of intangibles

General corporate expenses

Corporate asset impairment and exit costs

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Altria

Altria Group, Inc. operates as a holding company, which engages in the manufacture and sale of cigarettes in the United States. It operates through the following segments: Smokeable Products, Oral tobacco products, and Wine. The Smokeable Products segment consists of cigarettes manufactured and sold by PM USA and machine-made large cigars and pipe tobacco manufactured and sold by Middleton. The Oral tobacco products segment is primarily moist smokeless tobacco products (MSTs) through brands like Copenhagen and Skoal as well as on! oral nicotine pouches sold by Helix. The Wine segment, through subsidiary Ste. Michelle Wine Estates Ltd, produces Washington State wines, primarily Chateau Ste. Michelle and 14 Hands, and owns wineries in or distributes wines from several other wine regions. The company was founded in 1919 and is headquartered in Richmond, VA.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Altria reports robust Q4 earnings, focuses on innovation and growth

Altria's Q4 2022 performance reflects resilience amidst industry challenges, with a focus on innovation and shareholder returns. The company's strategic initiatives in smoke-free products and digital engagement underscore its commitment to long-term growth and harm reduction.

Altria reports resilient Q1 performance amid industry challenges and opportunities

Altria's Q1 2023 earnings call highlighted strong performance amidst industry challenges, emphasizing harm reduction and regulatory compliance. The company faces hurdles from inflation, regulatory changes, and evolving consumer behaviors, while focusing on growth opportunities in smoke-free products and strategic investments.

Altria reports solid Q2 earnings, eyes e-vapor growth opportunities

Altria's focus on smoke-free products and NJOY acquisition driving growth.
Challenges in the cigarette industry due to economic pressures and flavor bans.
Opportunities in the e-vapor category and expansion plans in the U.S.
Strong balance sheet and significant capital returns to shareholders.

Altria reports growth in earnings, navigates regulatory challenges in e-vapor

Altria's Q3 2023 earnings call highlighted solid financial performance, strategic focus on e-vapor products, and efforts to combat illegal vape products. The company faces challenges from regulatory uncertainties and illicit products but sees opportunities in expanding NJOY's reach and addressing market gaps.

Altria reports growth in smoke-free products amidst regulatory challenges

Altria's Q4 2023 earnings call highlighted growth in adjusted EPS, strategic focus on smoke-free products, and efforts to combat illicit e-vapor products. The company faces challenges in competitive segments and economic pressures but sees opportunities in new product introductions and regulatory collaborations.

Altria reports mixed Q1 performance, focuses on growth strategies

Altria's Q1 performance showed growth in NJOY and oral tobacco segments, with challenges in EPS decline and economic pressures on consumers.
Strengths include reaffirmed EPS guidance, strategic investments, and focus on combating illicit e-vapor products.
Opportunities lie in maximizing profitability in oral tobacco, product positioning, and capturing transitioning consumers.
Overall, Altria's performance reflects a mix of growth, challenges, and strategic opportunities in navigating market dynamics.

Altria's NJOY drives growth as company navigates e-vapor challenges

Altria's Q2 2024 earnings call showcased strong performance in smoke-free products, highlighting growth in retail share and volume momentum. Despite challenges in the e-vapor category, the company remains focused on responsible regulation and enforcement. With a commitment to shareholder value and long-term growth strategies, Altria is poised for continued success.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Altria Group, Inc. is a holding company, which engages in the manufacture and sale of cigarettes in the United States. It operates through the following segments: Smokeable Products, Oral Tobacco Products, and All Other. The Smokeable Products segment consists of cigarettes manufactured and sold by PM USA, and machine-made large cigars and pipe tobacco manufactured and sold by Middleton. The Oral Tobacco Products segment includes MST and snus products manufactured and sold by USSTC, and oral nicotine pouches manufactured and sold by Helix. The All Other segment refers to the financial results of NJOY, Helix ROW, and the IQOS System heated tobacco business. The company was founded in 1919 and is headquartered in Richmond, VA.

Japan Tobacco Inc

Altria and Japan Tobacco have identical annual revenue. Altria and Japan Tobacco have entered into an agreement to sell JAPAY's HTS (Heated Tobacco Stick) Ploom X in the US.

Altria Vs. Japan Tobacco: Which Company Is The Best Investment For 2023?

Coca-Cola

Procter & Gamble

Many Consumer Staples stocks pay dividends, providing a passive income stream and a cushion against the impacts of drawdowns. And these three stocks are no different, all currently yielding more than 2.5% annually.

Like Income? 3 Consumer Staples Stocks Worth a Look

Allianz SE

AXA SA

BHP Billiton

British American Tobacco

Corteva Inc

iShares Core Dividend Growth ETF

iShares Select Dividend ETF

Hartford Financial Services Group

Realty Income Corp

Philip Morris

Rio Tinto plc Sponsored

Schwab US Dividend Equity ETF

SPDR S&P Dividend ETF

Simon Property Group

SPDR S&P 500 ETF Trust

Sociedad Quimica Y Minera De Chile

AT&T

T-Mobile US

Vanguard S&P 500 ETF

Vanguard High Dividend Yield ETF

Verizon

Zurich Insurance Group AG

In this article, I will show you how you could build an investment portfolio that aims to reach a relatively high Dividend Yield. I will demonstrate how you could allocate $50,000 among 10 high yield dividend income companies and ETFs while achieving a broad risk diversification.

How To Allocate $50,000 Among 10 High Yield Dividend Income Stocks And ETFs

Energy Transfer LP Unit

FS KKR Capital Corp

Gladstone Commercial

Medical Properties Trust

New Fortress Energy

If you believe some of the top Wall Street strategists, the 2023 rally is almost over.

Dividend Lovers Are Flying Into These ‘Strong Buy' 7% or More Yielding Stocks

This tobacco company's 7.9% dividend yield remains highly attractive.

Want Massive Passive Income? Buy This Dividend Stock

Enbridge

First of Long Island

2023 has been a surprising and confusing year for everyone. If you're not confused, you're not paying attention. Fortunately, high-yield aristocrats are available to let you escape the rat race, by offering safe and growing income that can pay the bill no matter what happens next.

4 High-Yield Dividend Aristocrat Retirement Dream Buys

The company projects a growth rate of 3-6% for 2023 and recently approved a $1 billion share repurchase program. A projected annual return on investment rate of around 12% is expected going forward.

Altria: Stock Chart And Fundamentals Suggest It Is Currently Undervalued

Altria Group outperformed pessimistic consensus estimates with an impressive double beat on net revenue and adjusted EPS. Despite its resilience, the company faced a tough hit from macroeconomic headwinds as cost-conscious consumers traded down.

Altria: Pessimism Won't Last

Cardinal Health

Chubb

Embecta Corp

General Electric

GlaxoSmithKline

Illinois Tool Works

Johnson Controls

Kimberly-Clark

Leggett & Platt

Mondelez

PepsiCo

Dividends may not increase every year and a cut or elimination is even possible but the odds are greatly reduced when you diversify among different companies and sectors and focus on dividend quality. The market may move up and down irrationally and seemingly on a whim while our dividends remain much more stable, reliable, and predictable.

Dividend Income Update: January 2023

Tech is getting frosty again with some mega-caps gaining 100% from lows. Macro indicates a return to safety is on the cards.

Altria: Breaking Out

Altria looks like a surprisingly appealing buy, at least for some investors.

3 Reasons to Buy Altria Stock, and 1 Reason to Sell

AbbVie

Amgen

Clorox

Digital Realty Trust

iShares MSCI EAFE Growth ETF

iShares MSCI EAFE Value ETF

Fastenal

Home Depot

Johnson & Johnson

Lockheed Martin

McDonald's

Nuveen Build America Bond Fund

NextEra Energy

iShares Preferred and Income Securities ETF 

Invesco QQQ

Cohen & Steers Quality Income Realty Fund

iShares 1-3 Year Treasury Bond ETF

Proshares Short 20+ Year Treasury

iShares 20+ Year Treasury Bond ETF

Texas Instruments

Reaves Utility Income Fund

Vanguard Dividend Appreciation ETF

We will go over our thesis as to how a diversified income method with low volatility could make you financially independent. We regularly write about multi-basket income strategies with an in-built hedging mechanism to keep the drawdowns to a minimum. They provide not only consistent income but also long-term growth with 30% less volatility.

How This Income Method Could Lead To Financial Freedom

Ares Capital

Cisco Systems

Medtronic

Annaly Capital

Rithm Capital Corp

Stryker

Inflation and (expected) actions by the Federal Reserve continue to dominate market movements. Markets have started the new year with very solid gains following expectations about a more dovish Federal Reserve and a solid earnings season.

My Dividend Stock Portfolio: New January Record - 100 Holdings With 26 Buys

News for Altria Stock (MO)